 | • レポートコード：MRC2303J0174 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、238ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥732,452 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,472,452 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、世界の臨床意思決定支援システム（CDSS）市場規模が2021年に1,286.99百万ドル、2022年には1,441.32百万ドルに到達し、今後CAGR 12.78％で成長して2027年までに2,649.16百万ドルまで拡大すると予測しています。当調査資料では、臨床意思決定支援システム（CDSS）の世界市場について調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、アドバイスモード別（能動的CDSS、受動的CDSS）分析、システム別（エキスパートラボ情報システム、知識ベースシステム、機械学習システム）分析、エンドユーザー別（クリニック、診断センター、病院、小売薬局）分析、用途別（治療計画、診断決定サポート、疾患参照、薬剤データベース）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目をまとめております。なお、当書に掲載されている企業情報には、Allscripts Healthcare Solutions, Inc.、Cerner Corporation、Elsevier、Epic Systems Corporation, Inc.、EvidenceCare, LLC、First Databank, Inc.、GE Healthcare、IBM Watson Health、Koninklijke Philips N.V.、Nuanceなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の臨床意思決定支援システム（CDSS）市場規模：アドバイスモード別 - 能動的CDSSの市場規模 - 受動的CDSSの市場規模 ・世界の臨床意思決定支援システム（CDSS）市場規模：システム別 - エキスパートラボ情報システムの市場規模 - 知識ベースシステムの市場規模 - 機械学習システムの市場規模 ・世界の臨床意思決定支援システム（CDSS）市場規模：エンドユーザー別 - クリニックにおける市場規模 - 診断センターにおける市場規模 - 病院における市場規模 - 小売薬局における市場規模 ・世界の臨床意思決定支援システム（CDSS）市場規模：用途別 - 治療計画における市場規模 - 診断決定サポートにおける市場規模 - 疾患参照における市場規模 - 薬剤データベースにおける市場規模 ・世界の臨床意思決定支援システム（CDSS）市場規模：地域別 - 南北アメリカの臨床意思決定支援システム（CDSS）市場規模 アメリカの臨床意思決定支援システム（CDSS）市場規模 カナダの臨床意思決定支援システム（CDSS）市場規模 ブラジルの臨床意思決定支援システム（CDSS）市場規模 ... - アジア太平洋の臨床意思決定支援システム（CDSS）市場規模 日本の臨床意思決定支援システム（CDSS）市場規模 中国の臨床意思決定支援システム（CDSS）市場規模 インドの臨床意思決定支援システム（CDSS）市場規模 韓国の臨床意思決定支援システム（CDSS）市場規模 台湾の臨床意思決定支援システム（CDSS）市場規模 ... - ヨーロッパ/中東/アフリカの臨床意思決定支援システム（CDSS）市場規模 イギリスの臨床意思決定支援システム（CDSS）市場規模 ドイツの臨床意思決定支援システム（CDSS）市場規模 フランスの臨床意思決定支援システム（CDSS）市場規模 ロシアの臨床意思決定支援システム（CDSS）市場規模 ... - その他地域の臨床意思決定支援システム（CDSS）市場規模 ・競争状況 ・企業情報 |
The Global Clinical Decision Support System Market size was estimated at USD 1,286.99 million in 2021 and expected to reach USD 1,441.32 million in 2022, and is projected to grow at a CAGR 12.78% to reach USD 2,649.16 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Clinical Decision Support System to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Mode of Advice, the market was studied across Active CDSS and Passive CDSS.
Based on System, the market was studied across Expert Laboratory Information System, Knowledge-based System, and Machine Learning System.
Based on Delivery Mode, the market was studied across Cloud-Based and On-premise.
Based on End User, the market was studied across Clinics, Diagnostic Centers, Hospitals, and Retail Pharmacy.
Based on Application, the market was studied across Care Plans, Diagnostic Decision Support, Disease Reference, and Drug Databases.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Decision Support System market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Decision Support System Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Decision Support System Market, including Allscripts Healthcare Solutions, Inc., Cerner Corporation, Elsevier, Epic Systems Corporation, Inc., EvidenceCare, LLC, First Databank, Inc., GE Healthcare, IBM Watson Health, Koninklijke Philips N.V., Nuance, Optum, Inc., Premier, Inc., and Siemens Healthineers AG.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Clinical Decision Support System Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Decision Support System Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Decision Support System Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Decision Support System Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Decision Support System Market?
6. What is the market share of the leading vendors in the Global Clinical Decision Support System Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Decision Support System Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for improvement in the quality of care and reducing human errors in diagnostics and healthcare expenditure
5.1.1.2. Prominence of big data and mHealth solutions
5.1.1.3. Increasing adoption of cloud computing in healthcare
5.1.2. Restraints
5.1.2.1. Lack of trust CDSS and limited availability of skilled professionals
5.1.2.2. Concerns associated with the privacy and security of data
5.1.3. Opportunities
5.1.3.1. Technology development in the healthcare solutions
5.1.3.2. Collaboration between research institutes and clinical decision support providers
5.1.3.3. Growing adoption rates by the healthcare system of emerging economies
5.1.4. Challenges
5.1.4.1. High initial investment for healthcare IT infrastructure
5.1.4.2. Complicated integration of CDSS within healthcare organizations
5.2. Cumulative Impact of COVID-19
6. Clinical Decision Support System Market, by Mode of Advice
6.1. Introduction
6.2. Active CDSS
6.3. Passive CDSS
7. Clinical Decision Support System Market, by System
7.1. Introduction
7.2. Expert Laboratory Information System
7.3. Knowledge-based System
7.4. Machine Learning System
8. Clinical Decision Support System Market, by Delivery Mode
8.1. Introduction
8.2. Cloud-Based
8.3. On-premise
9. Clinical Decision Support System Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Centers
9.4. Hospitals
9.5. Retail Pharmacy
10. Clinical Decision Support System Market, by Application
10.1. Introduction
10.2. Care Plans
10.3. Diagnostic Decision Support
10.4. Disease Reference
10.5. Drug Databases
11. Americas Clinical Decision Support System Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Clinical Decision Support System Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Clinical Decision Support System Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Allscripts Healthcare Solutions, Inc.
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Cerner Corporation
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Elsevier
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Epic Systems Corporation, Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. EvidenceCare, LLC
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. First Databank, Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. GE Healthcare
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. IBM Watson Health
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Koninklijke Philips N.V.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Nuance
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Optum, Inc.
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Premier, Inc.
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Siemens Healthineers AG
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing